Dose-ranging study of fleroxacin for treatment of uncomplicated Chlamydia trachomatis genital infections.
Men and women with suspected or proven genital infections caused by Chlamydia trachomatis were enrolled in a double-blind study to evaluate the efficacy and tolerability of fleroxacin. Patients received either 400, 600, or 800 mg once daily for 7 days and were monitored approximately 2, 4, and 7 wee...
Guardado en:
| Publicado en: | Antimicrob Agents Chemother |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society for Microbiology (ASM)
1989
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172753/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2511801/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.33.10.1774 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|